Urinary Bladder Neoplasm Clinical Trial
Official title:
Holmium Versus Bipolar en Bloc Transurethral Resection of Urothelium Tumor of the Urinary Bladder: A Randomized Controlled Trial
En bloc resection of bladder tumors (ERBT) may improve staging quality and perioperative morbidity and influence tumour recurrence
Modern laser technology has led to new alternatives to conventional TURBT (cTURBT). The
advocates of ERBT have three goals: to improve resection quality, lower perioperative
complication rates, and decrease recurrence rates at resection sites. The present study is
the first to compare the results of laser and electric en bloc resection of bladder cancer
with respect to the aforementioned goals.
we aimTo compare the clinical outcome in the form of safety and efficacy between Holmium and
bipolar transurethral en bloc resection of urinary bladder tumors.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT05429710 -
SOX2 & PDL1 Expression on Urinary Bladder Carcinoma
|
||
| Not yet recruiting |
NCT05097105 -
Role of Diffusion -Weighted MRI in Evaluation of Urinary Bladder Masses
|
||
| Completed |
NCT02966535 -
The Effect of Prolonged Inspiratory Time on Gas Exchange During Robot-assisted Laparoscopic Surgery With Steep Trendelenburg Position : A Crossover Randomized Clinical Trial
|
N/A | |
| Completed |
NCT02977143 -
Positive End-expiratory Pressure-induced Increase in Central Venous Pressure as a Predictor of Fluid Responsiveness in Robot-assisted Laparoscopic Surgery
|
N/A | |
| Recruiting |
NCT04144270 -
The Importance of Muscle Function in Patients With Disseminated Bladder Cancer
|
||
| Completed |
NCT05946369 -
Neutrophils to Lymphocytes Ratio in Predicting the Response to BCG in Non-muscle Invasive Bladder Cancer
|
||
| Recruiting |
NCT05786716 -
DETERMINE Trial Treatment Arm 04: Trastuzumab in Combination With Pertuzumab in Adult, Teenage/Young Adult and Paediatric Patients With Cancers With HER2 Amplification or Activating Mutations
|
Phase 2/Phase 3 | |
| Recruiting |
NCT06238479 -
A Study of LY4101174 in Participants With Recurrent, Advanced or Metastatic Solid Tumors
|
Phase 1 | |
| Completed |
NCT02311101 -
Phase I Mitomycin Combined With Bacillus Calmette-Guérin (BCG) for Bladder Cancer
|
Phase 1 | |
| Recruiting |
NCT04811846 -
CTC Quantification During TURBT and PKVBT of Transitional Cell Carcinoma in Purging Fluid and Blood
|
N/A | |
| Not yet recruiting |
NCT06465069 -
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
|
Phase 1 | |
| Completed |
NCT02857634 -
Confocal Microscopy Dual Band in the Management of Bladder Cancer
|
||
| Recruiting |
NCT04561362 -
Study BT8009-100 in Subjects With Nectin-4 Expressing Advanced Malignancies
|
Phase 1/Phase 2 | |
| Recruiting |
NCT04442724 -
Bladder Fiducial Markers and Multiparametric-MRI (Mp-MRI) to Optimize Bladder Chemo-radiotherapy
|
N/A | |
| Recruiting |
NCT04029948 -
Laser vs. Electorsurgical Enbloc Resection of Bladder Tumours
|
N/A | |
| Terminated |
NCT03389438 -
Autologous Cellular Immunotherapy in Patients With Metastatic Bladder Urothelial Carcinoma
|
Phase 2 | |
| Terminated |
NCT02952989 -
A Safety Study of SGN-2FF for Patients With Advanced Solid Tumors
|
Phase 1 | |
| Recruiting |
NCT06237920 -
Stage II-IIIa Urothelial Cancer Randomizing Pre-operative Nivolumab With or Without Relatlimab
|
Phase 2 | |
| Completed |
NCT03785925 -
A Single-Arm Study of Bempegaldesleukin (NKTR-214) Plus Nivolumab in Cisplatin Ineligible Patients Who Have Locally Advanced or Metastatic Urothelial Cancer
|
Phase 2 | |
| Completed |
NCT03636256 -
Evaluation of NanoDoce® in Participants With Urothelial Carcinoma
|
Phase 1/Phase 2 |